References
|
1. |
|
Substance Abuse and Mental Health Services Administration. (2003). Results from the 2002 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NHSDA Series H-22, DHHS Publication No. SMA 03-3836). Rockville, MD. |
|
2. |
|
Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. JAMA 1998; 280:1936. |
|
3. |
|
Bruner, AB, Fishman, M. Adolescents and illicit drug use. JAMA 1998; 280:597. |
|
4. |
|
Reisine, T, Pasternak, G. Opioid analgesics and antagonists. In: Hardman, JG, Gilman, A, Limbird, LE (Eds), Pharmacological Basis of Therapeutics, 9th Ed, McGraw-Hill, New York, 1996. p.521. |
|
5. |
|
Way, WL, Way, EL. Opioid analgesics and antagonists. In: Katzung, BG (Ed), Basic and Clinical pharmacology, Appleton & Lange, Norwalk, CT, 1989. p.368. |
|
6. |
|
Watson, SJ, Akil, H, Khachaturian, H, et al. Opioid systems: Anatomical, physiological and clinical perspectives. In: Hughes, J, Collier, HO, Rance, MJ, Tyers, MB (Eds), Opioids Past, Present and Future, Taylor & Francis, London, 1984. p.145. |
|
7. |
|
Sporer, KA. Acute heroin overdose. Ann Intern Med 1999; 130:584. |
|
8. |
|
Community Epidemiology Work Group. Epidemiologic Trends in Drug Abuse, Vol. II. Proceedings of the Community Epidemiology Work Group, December 2003. NIH Pub No. 04-5365. Bethesda, MS: NIDA, NIH, DHHS, 2004. |
|
9. |
|
Cicero, TJ, Inciardi, JA, Munoz, A. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. J Pain 2005; 6:662. |
|
10. |
|
Substance Abuse and Mental Health Services Administration. (2006). Results from the 2005 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-30, DHHS Publication No. SMA 06-4194). Rockville, MD. |
|
11. |
|
Rosenblum, A, Parrino, M, Schnoll, SH, et al. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend 2007; 90:64. |
|
12. |
|
Brands, B, Blake, J, Sproule, B, et al. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug Alcohol Depend 2004; 73:199. |
|
13. |
|
Trafton, JA, Oliva, EM, Horst, DA, et al. Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment. Drug Alcohol Depend 2004; 73:23. |
|
14. |
|
Sigmon, SC. Characterizing the emerging population of prescription opioid abusers. Am J Addict 2006; 15:208. |
|
15. |
|
de Paula, M, Saiz, LC, Gonzalez-Revalderia, J, et al. Rifampicin causes false-positive immunoassay results for urine opiates. Clin Chem Lab Med 1998; 36:241. |
|
16. |
|
Baden, LR, Horowitz, G, Jacoby, H, Eliopoulos, GM. Quinolones and false-positive urine screening for opiates by immunoassay technology. JAMA 2001; 286:3115. |
|
17. |
|
Pettitt, BC Jr, Dyszel, SM, Hood, LV. Opiates in poppy seed: effect on urinalysis results after consumption of poppy seed cake-filling. Clin Chem 1987; 33:1251. |
|
18. |
|
Gronbladh, L, Ohlund, LS, Gunne, LM. Mortality in heroin addiction: impact of methadone treatment [see comments]. Acta Psychiatr Scand 1990; 82:223. |
|
19. |
|
Howe, CJ, Fuller, CM, Ompad, DC, et al. Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City. Drug Alcohol Depend 2005; 79:389. |
|
20. |
|
Tortu, S, McMahon, JM, Pouget, ER, Hamid, R. Sharing of noninjection drug-use implements as a risk factor for hepatitis C. Subst Use Misuse 2004; 39:211. |
|
21. |
|
McMahon, JM, Tortu, S. A potential hidden source of hepatitis C infection among noninjecting drug users. J Psychoactive Drugs 2003; 35:455. |
|
22. |
|
Moore MH. Policies to achieve discrimination on the effective price of heroin. Am Econ Rev 1973; 63:270. |
|
23. |
|
Johnson BD, Golub A. The potential for accurately measuring behavioral and economic dimensions of consumption, prices, and markets for illegal drugs. Drug Alcohol Depend 2007;90S:S16. |
|
24. |
|
Weatherburn, D, Lind, B. The impact of law enforcement activity on a heroin market. Addiction 1997; 92:557. |
|
||||||||||||
|
||||||||||||
|
printer-friendly
format
e-mail
this to a colleague
